Effects of CDP-Choline Treatment on Neurobehavioral Deficits after TBI and on Hippocampal and Neocortical Acetlycholine Release
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The exogenous administration of cytidine-5'-diphosphate (CDP)-choline has been used extensively as a brain activator in different neurological disorders that are associated with memory deficits. A total of 50 rats were utilized to (a) determine whether exogenously administered CDP-choline could attenuate posttraumatic motor and spatial memory performance deficits and (b) determine whether intraperitoneal (i.p.) administration of CDP-choline increases acetylcholine (ACh) release in the dorsal hippocampus and neocortex. In the behavioral study, traumatic brain injury (TBI) was produced by lateral controlled cortical impact (2-mm deformation/6 m/sec) and administered CDP-choline (100 mg/kg) or saline daily for 18 days beginning 1 day postinjury. At 1 day postinjury, rats treated with CDP-choline 15 min prior to assessment performed significantly better than saline-treated rats. Between 14-18 days postinjury, CDP-choline-treated rats had significantly less cognitive (Morris water maze performance) deficits that injured saline-treated rats. CDP-choline treatment also attenuated the TBI-induced increased sensitivity to the memory-disrupting effects of scopolamine, a muscarinic antagonist. The microdialysis studies demonstrated for the first time that a single i.p. administration of CDP-choline can significantly increase extracellular levels of ACh in dorsal hippocampus and neocortex in normal, awake, freely moving rats. This article provides additional evidence that spatial memory performance deficits are, at least partially, associated with deficits in central cholinergic neurotransmission and that treatments that enhance ACh release in the chronic phase after TBI may attenuate cholinergic-dependent neurobehavioral deficits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508 · cited 1×
“…(Clifton et al., 1991; Marion and White, 1996), lipid peroxidation inhibitors (Althaus et al., 1993; Mclntosh et al., 1992), receptor antagonists (Faden et al., 1988; Hayes et al., 1988; Lyeth et al., 1988; Smith et al., 1993), and more recently, protease inhibitors (Saat-man et al., 1996).”
A controlled cortical impact model of traumatic brain injury in the rat
Edward Dixon, C., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., & Hayes, R. L. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90104-8 · Cited by 1,141 · cited 2×
“Numerous previous studies have demonstrated that rats injured at this magnitude of CCI injury do not have reduced swimming speeds at 2 weeks postinjury (Dixon et al., 1991; Hamm et al., 1992; Long et al., 1996).”
Influential
Cited by
Motor and cognitive function evaluation following experimental traumatic brain injury
Fujimoto, S. T., Longhi, L., Saatman, K. E., & McIntosh, T. K. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.06.002 · Cited by 299
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
McINTOSH, T. K., JUHLER, M., & WIELOCH, T. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.731 · Cited by 298
Cognitive impairment following traumatic brain injury
Arciniegas, D. B., Held, K., & Wagner, P. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0004-6 · Cited by 263
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis
Bales, J. W., Wagner, A. K., Kline, A. E., & Dixon, C. E. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.03.011 · Cited by 264
Self-citationNeurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Metadata
- Authors
- DIXON, C. E., MA, X., & MARION, D. W.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 1997-03
- Volume
- 14
- Issue
- 3
- Pages
- 161-169
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2006001085
- Cited by
- 148
- References
- 2
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of CDP-Choline Treatment on Neurobehavioral Deficits after TBI and on Hippocampal and Neocortical Acetlycholine Release. https://app.cochat.ai/papers/10.1089/neu.1997.14.161
- The paper
- DIXON, C. E., MA, X., & MARION, D. W. (1997). Effects of CDP-Choline Treatment on Neurobehavioral Deficits after TBI and on Hippocampal and Neocortical Acetlycholine Release. Journal of Neurotrauma. https://doi.org/10.1089/neu.1997.14.161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.